The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Regulatory News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 637.00
Bid: 626.00
Ask: 642.00
Change: 0.00 (0.00%)
Spread: 16.00 (2.556%)
Open: 637.00
High: 0.00
Low: 0.00
Prev. Close: 637.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights - Replacement

2 Mar 2020 12:04

RNS Number : 7073E
Intl. Biotechnology Trust PLC
02 March 2020
 

International Biotechnology Trust plc (the "Company")

 

 

The following amendments have been made to the 'Total Voting Rights' announcement released on 28 February 2020 at 17:18 under RNS No 5778E.

 

The total number of shares held in Treasury has been amended from 2,903,176 to 2,916,476.

 

The total voting rights in the Company has been amended from 38,439,487 to 38,426,187.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Voting Rights and Capital

 

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R the Company would like to notify the market of the following:

 

At the close of business on the 28 February 2020, the Company had 41,342,663 Ordinary shares in issue, of which 2,916,476 were held in Treasury. Therefore the total number of voting rights in the Company was 38,426,187.

 

The above figure (38,426,187) may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Susan Gledhill

For and on behalf of

BNP Paribas Secretarial Services Limited

Company Secretary

 

Telephone: 020 7410 5971

 

 

2 MARCH 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRSSEFEEESSESD
Date   Source Headline
3rd Aug 20232:43 pmRNSDirector/PDMR Shareholding
3rd Aug 202311:52 amPRNNet Asset Value(s)
3rd Aug 202311:41 amRNSKepler Trust Intelligence: Flash Update
3rd Aug 20237:00 amRNSAppointment of New Fund Manager
2nd Aug 202311:07 amPRNNet Asset Value(s)
1st Aug 202310:59 amPRNNet Asset Value(s)
1st Aug 20239:57 amRNSTotal Voting Rights
31st Jul 202311:48 amPRNNet Asset Value(s)
28th Jul 20235:11 pmRNSTransaction in Own Shares
28th Jul 202311:47 amPRNNet Asset Value(s)
27th Jul 202311:51 amPRNNet Asset Value(s)
26th Jul 20235:04 pmRNSTransaction in Own Shares
26th Jul 202310:46 amPRNNet Asset Value(s)
26th Jul 20238:00 amRNSPortfolio Update
25th Jul 202312:16 pmPRNNet Asset Value(s)
24th Jul 202311:22 amPRNNet Asset Value(s)
21st Jul 202311:08 amPRNNet Asset Value(s)
20th Jul 202310:57 amPRNNet Asset Value(s)
19th Jul 20235:40 pmRNSTransaction in Own Shares
19th Jul 202311:26 amPRNNet Asset Value(s)
18th Jul 202311:41 amPRNNet Asset Value(s)
17th Jul 20235:19 pmRNSTransaction in Own Shares
17th Jul 202310:43 amPRNNet Asset Value(s)
14th Jul 202311:01 amPRNNet Asset Value(s)
14th Jul 20239:23 amPRNNet Asset Value(s)
12th Jul 20231:28 pmPRNNet Asset Value(s)
11th Jul 20234:35 pmRNSTransaction in Own Shares
11th Jul 202311:47 amPRNNet Asset Value(s)
10th Jul 20235:00 pmRNSTransaction in Own Shares
10th Jul 202312:02 pmPRNNet Asset Value(s)
10th Jul 202310:40 amEQSHardman & Co Research on International Biotechnology Trust (IBT): Industry M&A remains a key driver
7th Jul 20235:31 pmRNSTransaction in Own Shares
7th Jul 202310:27 amPRNNet Asset Value(s)
6th Jul 20235:21 pmRNSTransaction in Own Shares
6th Jul 202310:48 amPRNNet Asset Value(s)
5th Jul 20236:04 pmRNSDividend Declaration
5th Jul 20235:26 pmRNSTransaction in Own Shares
5th Jul 20234:22 pmRNSDirector Declaration
5th Jul 202310:01 amPRNNet Asset Value(s)
4th Jul 202310:42 amPRNNet Asset Value(s)
3rd Jul 20234:55 pmRNSTransaction in Own Shares
3rd Jul 202310:10 amPRNNet Asset Value(s)
3rd Jul 202310:09 amRNSBlock listing Interim Review
3rd Jul 202310:07 amRNSTotal Voting Rights
30th Jun 20234:57 pmRNSTransaction in Own Shares
30th Jun 202310:10 amPRNNet Asset Value(s)
29th Jun 202310:54 amPRNNet Asset Value(s)
28th Jun 20234:59 pmRNSTransaction in Own Shares
28th Jun 202310:42 amPRNNet Asset Value(s)
27th Jun 20234:21 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.